A European survey of diagnostic methods and testing protocols for Clostridium difficile

Clinical Microbiology and Infection

Volumn 9, Issue 10, 2003, Pages 989-996

  Barbut, F ^a   Delmee N ^b   Brazier, Jon ^c   Petit, J C ^a   Poxton, I R ^d   Rupnik, M ^e   Lalande, V ^a   Schneider, C ^f   Mastrantonio, P ^g   Alonso, R ^h   Kuipjer, E ⁱ   Tvede, M ^j  

^a HÔPITAL SAINT ANTOINE   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF LJUBLJANA   (Slovenia)

^f Institute for Microbiology/Hygiene   (Germany)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j Laboratory of Microbiology   (Denmark)

more..

Author keywords

Clostridium difficile; Culture; Cytotoxicity assay; Diagnosis; Diarrhea; Enzyme immunoassays; Toxins

Indexed keywords

CLOSTRIDIUM TOXIN; GLUTAMATE DEHYDROGENASE;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIARRHEA; ENZYME ASSAY; ENZYME IMMUNOASSAY; EUROPE; HOSPITAL BED; HOSPITAL LABORATORY; HOSPITALIZATION; HUMAN; INCIDENCE; MICROBIOLOGY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE;

EID: 10744225600     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00683.x     Document Type: Article

References (34)

1. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978: 1063-5.
2. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin producing Clostridia. N Engl J Med 1978; 298: 531-4.
3. Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18: S265-72.
4. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330: 257-62.
5. Cartmill TD, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hospital Infection 1994; 27: 1-15.
6. Barbut F, Leluan P, Antoniotti G, Collignon A, Sédallian A, Petit JC. Value of routine stool culture in hospitalized patients with diarrhea. Eur J Clin Microbiol Infect Dis 1995; 14: 10-3.
7. Rohner P, Pittet D, Pepey B, Nije-Kinge T, Auckenthaler R. Etiological agents of infectious diarrhea: implications for requests for. J Clin Microbiol 1997; 35: 1427-32.
8. Barbut F, Corthier G, Charpak Y et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a french multicenter study. Arch Intern Med 1996; 156: 1449-54.
9. Brazier JS. Role of the laboratory in investigations of Clostridium difficile diarrhea. Clin Infect Dis 1993; 16: S228-33.
10. Delmée M. Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 2001; 7: 411-6.
11. Wren B, Clayton C, Castledine NB, Tabaqchali S. Identification of toxigenic Clostridium difficile strains by using a toxin A gene-specific probe. J Clin Microbiol 1990; 28: 1808-12.
12. Barbut F, Kajzer C, Planas N, Petit JC. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile associated diarrhea. J Clin Microbiol 1993; 31: 963-7.
13. Barbut F, Revel R, Ephraim R, Leluan P, Lureau P, Petit JC. Evaluation of a rapid enzyme immunoassay for the detection of Clostridium difficile in stools. Eur J Clin Microbiol Infect Dis 1994; 13: 277-8.
14. Barbut F, Macé M, Lalande V, Tilleul P, Petit JC. Rapid detection of Clostridium difficile toxin A in stool specimens. Clin Microbiol Infect 1997; 3: 480-3.
15. Delmée M, Mackey T, Hamitou A. Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools. Eur J Clin Microbiol Infect Dis 1992; 11: 246-9.
16. Doern GV, Coughlin RT, Wu L. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays. J Clin Microbiol 1992; 30: 2042-6.
17. Fedorko DP, Engler HD, O'Shaughnessy EM, Williams EC, Reichelderfer CJ, Smith WIJ. Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens. J Clin Microbiol 1999; 37: 3044-7.
18. Mattia AR, Doern GV, Clark J, Holden J, Wu L, Ferraro MJ. Comparison of four methods in the diagnosis of Clostridium difficile disease. Eur J Clin Microbiol Infect Dis 1993; 12: 882-6.
19. Merz CS, Kramer C, Forman M et al. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol 1994; 32: 1142-7.
20. Peterson LR, Kelly PJ, Nordbrock HA. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile associated diarrhea. Eur J Clin Microbiol Infect Dis 1996; 15: 330-6.
21. Wilson KH, Kennedy MJ, Fekety FR. Use of taurocholate to enhance spore recovery on a media selective for Clostridium difficile. J Clin Microbiol 1982; 15: 443-6.
22. Staneck JL, Weckbach LS, Allen SD et al. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J Clin Microbiol 1996; 34: 2718-21.
23. Laughon BE, Viscidi RP, Gdovin SL, Yolken RH. Bartlett. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infectious Dis 1984; 149: 781-8.
24. Reisner B, Woods GL, Thomson RB, Larone DH, Garcia LS, Shimizu RY. Specimen processing. In: PR M., eds. Manual of Clinical Microbiology. Washington, DC: ASM Press 1999: 64-104.
25. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-50.
26. Barbut F, Lalande V, Burghoffer B, Vu Thien H, Grimprel E, Petit J-C. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 2002; 40: 2079-83.
27. Brazier JS, Stubbs SL, Duerden BI. Prevalence of toxin A negative/B positive Clostridium difficile strains. J Hospital Infection 1999; 42: 248-9.
28. Borriello SP. Pathogenesis of Clostridium difficile infection. J Antimicrobial Chemotherapy 1998; 41: 13-9.
29. Lozniewski A, Rabaud C, Dotto E, Weber M, Mory F. Laboratoryn diagnosis of Clostidium difficile-associated diarrhea and colitis: usefulness of Premier cytoclone A+B enzyme immunoassay for combined of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 2001; 39: 1996-8.
30. Bond F, Payne G, Borriello SP, Humphreys H. Usefulness of culture in the diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 1995; 14: 223-6.
31. Riley TV. Clostridium difficile down under. Clin Infect Dis 1997; 25: S249-50.
32. Bowen KE, McFarland LV, Greenberg RN, Ramsey MM, Record KE, Svenson J. Isolation of Clostridium difficile at a University hospital: a two year study. Clin Infect Dis 1995; 20: S261-2.
33. Lai KK, Melvin ZS, Menard MJ, Kotilainen HR, Baker S. Clostridium difficile-associated diarrhea: epidemiology, risk factors and infection control. Infection Control Hospital Epidemiol 1997; 18: 628-32.
34. Olson MM, Shanholtzer CJ, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile disease surveillance and treatment at the Minneapolis VA Medical center, 1982-91. Infection Control Hospital Epidemiol 1994; 15: 371-81.